歌華有線(600037.SH)半年度淨利潤降82.83%至7487萬元
格隆匯 8 月 28日丨歌華有線(600037.SH)發佈2020年半年度報告,實現營業收入11.80億元,同比下降3.26%;歸屬於母公司所有者的淨利潤7487萬元,同比下降82.83%;歸屬於上市公司股東的扣除非經常性損益的淨利潤8125.29萬元,同比下降66.19%;基本每股收益0.0538元。
因為公司持有的金融資產公允價值同比降幅較大,疊加疫情影響導致公司半年度利潤下滑幅度較大。
截至6月底,公司在市場推廣和用户服務發展工作受到疫情影響的情況下,有線電視註冊用户達到601萬户,較2019年底增長2萬户;公司家庭寬帶在線總用户68萬户;高清交互用户累計達到555萬户。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.